USPTO serial 76291298
SPECTRAL GENOMICS
Reviewed by CopyMark Law Group
Reg. 3110800Status 710
- Filing date
- Status date
- Registration date
- Jul 4, 2006
- Examiner
- SMITH, BRIDGETT G
- Law office
- POST REGISTRATION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SPECTRAL GENOMICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
WELLESLEY, MA
PERKINELMER HEALTH SCIENCES, INC.
WALTHAM, MA
Houston, TX
Houston, TX
Houston, TX
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane L. Gardner
SONIA GUTERMAN PHD MINTZ LEVIN COHN FERRIS GLOVSKY & POPEOONE FINANCIAL CTRBOSTON, MA 02111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for scientific and research use, namely nucleic acid sequences for use in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses | SECTION 8 - CANCELLED | Nov 1, 2000 |
| 005 | Pharmaceutical products for clinical and medical use, namely nucleic acids sequences for us in analysis of biopolymers and biological samples, detecting diseases, determining the progression of diseases, and determining drug responses; diagnostic medical reagents for us in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer, comprised of reagents, processing chemicals and solid matrix materials | SECTION 8 - CANCELLED | Nov 1, 2000 |
| 009 | Scientific measuring apparatus and instruments, namely substrate chips used in the measurement of biopolymers and biological samples; genomic arrays, namely arrays of polypeptides, nucleic acids and proteins on substrates for use in genomic analysis; biochips used for genomic hybridization, genomic profiling, DNA copy number estimation, gene duplication and deletion detection,and transcript factor comparisons; computer hardware and computer software and related user manuals used for generating genome-wide molecular karyotype profiles from biopolymers and biological samples for analysis and for analyzing images of labeled chromosomes therefrom, namely computer hardware and computer software for retrieving image data from array scanners and displaying data as color-enhanced graphic presentations namely, chromosomal ideograms,fluorescence intensity ratio profiles and plots, highlighted chromosomal deletions and amplifications and detailed tabular images of clones overlapping defects, all of the aforementioned presentations used for interpretation and analysis | SECTION 8 - CANCELLED | Nov 1, 2000 |
| 042 | Testing and analysis of biopolymers and biological samples for others; design for others of customized substrate chips used in the measurement of biopolymers and biological samples; design of customized arrays for others; providing technical support, namely troubleshooting customer problems with scientific measuring apparatus and instruments, namely substrate chips used in the measurement of biopolymers and biological samples; providing technical support, namely troubleshooting customer problems with computer hardware and computer software used for generating genome-wide molecular karyotype profiles from biopolymers and biological samples for analysis and for analyzing images of labeled chromosomes, namely computer hardware and computer software for retrieving image data from array scanners and displaying data as color-enhanced graphic presentations namely, chromosomal ideograms, fluorescence intensity ratio profiles and plots, highlighted chromosomal deletions and amplifications and detailed tabular images of clones overlapping defects, all of the aforementioned presentations for interpretation and analysis | SECTION 8 - CANCELLED | Nov 1, 2000 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PERKINELMER LAS, INC.
- Other trademarks owned by PERKINELMER HEALTH SCIENCES, INC.
- Other trademarks owned by Spectral Genomics, Inc.
- Other trademarks owned by Spectral Genomics, Inc.
- Other trademarks owned by Spectral Genomics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named SPECTRAL GENOMICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 8, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 4, 2009 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 18, 2006 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Sep 8, 2006 | PAPER RECEIVED | — | |
| Aug 2, 2006 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 4, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 11, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 21, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 17, 2006 | ALIE | ASSIGNED TO LIE | — |
| Feb 17, 2006 | ALIE | ASSIGNED TO LIE | — |
| Feb 15, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 19, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 4, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2006 | PAPER RECEIVED | — | |
| Jun 30, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2004 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 1, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 20, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 20, 2004 | PAPER RECEIVED | — | |
| Oct 24, 2003 | CFIT | CASE FILE IN TICRS | — |
| Sep 17, 2003 | FAXX | FAX RECEIVED | — |
| Aug 12, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 4, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Aug 22, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 22, 2002 | PAPER RECEIVED | — | |
| Mar 20, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 8, 2002 | PAPER RECEIVED | — | |
| Feb 19, 2002 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Sep 21, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 7, 2001 | DOCK | ASSIGNED TO EXAMINER | — |